Steris (STE) Cash & Equivalents Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -69.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.03% |
| Dec 31, 2025 | 173.04% |
| Sep 30, 2025 | 85.37% |
| Jun 30, 2025 | 41.03% |
| Mar 31, 2025 | -17.06% |
| Dec 31, 2024 | -20.66% |
| Sep 30, 2024 | -19.44% |
| Jun 30, 2024 | -4.93% |
| Mar 31, 2024 | -0.64% |
| Dec 31, 2023 | -24.59% |
| Sep 30, 2023 | -17.23% |
| Jun 30, 2023 | -34.05% |
| Mar 31, 2023 | -40.18% |
| Dec 31, 2022 | -27.77% |
| Sep 30, 2022 | -32.66% |
| Jun 30, 2022 | -40.85% |
| Mar 31, 2022 | 57.95% |
| Dec 31, 2021 | 42.21% |
| Sep 30, 2021 | 22.90% |
| Jun 30, 2021 | 109.20% |
| Mar 31, 2021 | -30.99% |
| Dec 31, 2020 | 26.74% |
| Sep 30, 2020 | 38.35% |
| Jun 30, 2020 | 7.38% |
| Mar 31, 2020 | 44.85% |
| Dec 31, 2019 | -11.42% |
| Sep 30, 2019 | 7.44% |
| Jun 30, 2019 | 8.94% |
| Mar 31, 2019 | 9.48% |
| Mar 31, 2018 | -28.77% |